TAKEDA PHARMACEUTICAL CO LTD - 17 Sep 2025 SCHEDULE 13D/A Report for HILLEVAX, INC. Common Stock, par value $0.0001 per share (HLVX)

Filing Manager
TAKEDA PHARMACEUTICAL CO LTD
Reporting Manager
Takeda Pharmaceutical Company Limited
Security
HILLEVAX, INC. Common Stock, par value $0.0001 per share
Symbol
HLVX
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13D/A
Filing time
19 Sep 2025, 07:22:18 UTC
Date of event
17 Sep 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Takeda Pharmaceutical Company Limited 0% 0 0 0 /s/ Paul Sundberg Paul Sundberg / Authorized Signatory 0001395064
Takeda Vaccines Inc. 0% 0 0 0 /s/ Max Heuer Max Heuer / Authorized Signatory 0001905616